Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study
作者： Cristiano Oliva , Paola Bergnolo , Manuela Inguì , Lavinia Bianco , Paolo Pochettino
DOI: 10.1007/S00432-009-0671-8
关键词: Fluorouracil 、 Metastatic breast cancer 、 Vinorelbine 、 Breast disease 、 Breast cancer 、 Taxane 、 Chemotherapy 、 Oncology 、 Anthracycline 、 Internal medicine 、 Surgery 、 Medicine
摘要: Purpose This phase II study was designed in order to evaluate efficacy and safety of the combination vinorelbine (VNB), fluorouracil (FU) leucovorin (LV) patients with metastatic breast carcinoma (MBC) previously treated anthracyclines taxanes.
springer.com
sci-hub.se 参考文章(23)
Sue Carrick, Sharon Parker, Charlene E Thornton, Davina Ghersi, John Simes, Nicholas Wilcken, Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews. ,vol. 2009, ,(2009) , 10.1002/14651858.CD003372.PUB3
Alfredo Berruti, Paola Sperone, Alberto Bottini, Gabriella Gorzegno, Vito Lorusso, Antonio Brunelli, Mario Botta, Marco Tampellini, Michela Donadio, Sergio Mancarella, Mario De Lena, Palmiro Alquati, Luigi Dogliotti, Phase II Study of Vinorelbine With Protracted Fluorouracil Infusion as a Second- or Third-Line Approach for Advanced Breast Cancer Patients Previously Treated With Anthracyclines Journal of Clinical Oncology. ,vol. 18, pp. 3370- 3377 ,(2000) , 10.1200/JCO.2000.18.19.3370
A de Gramont, J F Bosset, C Milan, P Rougier, O Bouché, P L Etienne, F Morvan, C Louvet, T Guillot, E François, L Bedenne, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology. ,vol. 15, pp. 808- 815 ,(1997) , 10.1200/JCO.1997.15.2.808
Richard Hansen, Edward Quebbeman, Peter Beatty, Paul Ritch, Tom Anderson, David Jenkins, Jacob Frick, Robert Ausman, Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Research and Treatment. ,vol. 10, pp. 145- 149 ,(1987) , 10.1007/BF01810577
Bojana Pajk, Tanja Cufer, Peter Canney, Paul Ellis, David Cameron, Emmanuel Blot, Jan Vermorken, Robert Coleman, Sandrine Marreaud, Jan Bogaerts, Gul Basaran, Martine Piccart, Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial The Breast. ,vol. 17, pp. 180- 185 ,(2008) , 10.1016/J.BREAST.2007.09.002
Kim A. Margolin, Stephanie Green, Kent Osborne, James H. Doroshow, Steven A. Akman, Lucille A. Leong, Robert J. Morgan, James W. Raschko, George Somlo, Laura Hutchins, Christine Upchurch, Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer. American Journal of Clinical Oncology. ,vol. 17, pp. 175- 180 ,(1994) , 10.1097/00000421-199404000-00018
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, M. J. Thun, Cancer statistics, 2005. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 10- 30 ,(2005) , 10.3322/CANJCLIN.55.1.10
Max Mano, Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy Cancer Treatment Reviews. ,vol. 32, pp. 106- 118 ,(2006) , 10.1016/J.CTRV.2005.12.008
Mario Campone, Maria Blasinska-Morawiec, Anna Tekiela, Piotr Koralewski, Jean-Christophe Pouget, Isabelle Douville, Maud Brandely, Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer Cancer Chemotherapy and Pharmacology. ,vol. 63, pp. 937- 943 ,(2009) , 10.1007/S00280-008-0816-5
Richard Simon, Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials. ,vol. 10, pp. 1- 10 ,(1989) , 10.1016/0197-2456(89)90015-9